Skip to main content
Journal cover image

Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007.

Publication ,  Journal Article
Ranasinghe, I; Alprandi-Costa, B; Chow, V; Elliott, JM; Waites, J; Counsell, JT; Lopéz-Sendón, J; Avezum, A; Goodman, SG; Granger, CB; Brieger, D
Published in: Am J Cardiol
September 1, 2011

It is unclear if clinician risk stratification has changed with time. The aim of this study was to assess the temporal change in the concordance between patient presenting risk and the intensity of evidence-based therapies received for non-ST-segment elevation acute coronary syndromes over a 9-year period. Data from 3,562 patients with non-ST-segment elevation acute coronary syndromes enrolled in the Australian and New Zealand population of the Global Registry of Acute Coronary Events (GRACE) from 1999 to 2007 were analyzed. Patients were stratified to risk groups on the basis of the GRACE risk score for in-hospital mortality. Main outcome measures included in-hospital use of widely accepted evidence-based medications, investigations, and procedures. Invasive management was consistently higher in low-risk patients than in intermediate- or high-risk patients (coronary angiography 66.7% vs 63.5% vs 35.3%, p <0.001; percutaneous coronary intervention 31.1% vs 22.0% vs 12.9%, p <0.001). Absolute rates of angiography and percutaneous coronary intervention in the high-risk group remained 24% and 15% lower compared to the low-risk group in the most recent time period (2005 to 2007). In-hospital use of thienopyridine, low-molecular weight heparin, and glycoprotein IIb/IIIa inhibitors showed a similar inverse relation with risk. Prescription of aspirin, β blockers, statins, and angiotensin receptor blockers was inversely related to risk before 2004, although this inverse relation was no longer present in the most recent time period (2005 to 2007). Only in-hospital use of unfractionated heparin showed use concordant with patient risk status. In conclusion, despite an overall increase in the uptake of evidence-based therapies, most investigations and treatments are not targeted on the basis of patient risk. Clinician risk stratification remains suboptimal compared to objective measures of patient risk.

Duke Scholars

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

September 1, 2011

Volume

108

Issue

5

Start / End Page

617 / 624

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Survival Analysis
  • Severity of Illness Index
  • Risk Assessment
  • Registries
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • New Zealand
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ranasinghe, I., Alprandi-Costa, B., Chow, V., Elliott, J. M., Waites, J., Counsell, J. T., … Brieger, D. (2011). Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. Am J Cardiol, 108(5), 617–624. https://doi.org/10.1016/j.amjcard.2011.04.005
Ranasinghe, Isuru, Bernadette Alprandi-Costa, Vincent Chow, John M. Elliott, Jonathon Waites, John T. Counsell, Jose Lopéz-Sendón, et al. “Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007.Am J Cardiol 108, no. 5 (September 1, 2011): 617–24. https://doi.org/10.1016/j.amjcard.2011.04.005.
Ranasinghe I, Alprandi-Costa B, Chow V, Elliott JM, Waites J, Counsell JT, et al. Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. Am J Cardiol. 2011 Sep 1;108(5):617–24.
Ranasinghe, Isuru, et al. “Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007.Am J Cardiol, vol. 108, no. 5, Sept. 2011, pp. 617–24. Pubmed, doi:10.1016/j.amjcard.2011.04.005.
Ranasinghe I, Alprandi-Costa B, Chow V, Elliott JM, Waites J, Counsell JT, Lopéz-Sendón J, Avezum A, Goodman SG, Granger CB, Brieger D. Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007. Am J Cardiol. 2011 Sep 1;108(5):617–624.
Journal cover image

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

September 1, 2011

Volume

108

Issue

5

Start / End Page

617 / 624

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Survival Analysis
  • Severity of Illness Index
  • Risk Assessment
  • Registries
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • New Zealand
  • Middle Aged
  • Male